Business, energy, technology, markets and global industry news from Business News Today

aura6000 System

PharmaDeviceNews aura6000 System
Representative image of a hypoglossal nerve stimulation implant procedure used in obstructive sleep apnea treatment, reflecting how LivaNova PLC’s aura6000 System FDA approval could expand eligibility beyond traditional PAP therapy patients.
Medical Devices & Diagnostics

LivaNova PLC expands sleep apnea eligibility as aura6000 gains FDA approval without CCC limits

LivaNova PLC secures FDA approval for aura6000. Discover how it could reshape sleep apnea treatment and expand patient eligibility.

Read More